Sort
130,381 grants matching “hiv”
Testing practical microbicides in macaques
$783,535Ronald S. Veazey · Weill Medical Coll Of Cornell Univ · U19 · FY2010 · AI
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,487Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Alcohol Use Disorder Treatment Simulation: Modeling treatment impacts on alcohol-related disparities
$783,430Katherine J. Karriker-Jaffe · Research Triangle Institute · R01 · FY2024 · AA
A RCT of HIV Adherence Case Management and Modified DOT
$783,429University Of California San Francisco · R01 · FY2005 · MH
Strengthening Research Infrastructure at Lincoln University
$783,408Ivory V. Nelson · Lincoln University · P20 · FY2010 · MD
SHIV-guided design of novel HIV-1 fusion peptide immunogens
$783,400George M Shaw · University Of Pennsylvania · R01 · FY2025 · AI
Determinants of Functional Immune Defects in Treated HIV Infection and Aging
$783,355Peter W Hunt · University Of California, San Francisco · R01 · FY2018 · AI
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
$783,353Qing Ma · State University Of New York At Buffalo · R01 · FY2023 · AG
Implementation of an HIV Status-Neutral Nurse-Led Intervention to Increase Equity in Clinical Outcomes for Male HIV Self-Testers in Tanzania
$783,348Donaldson Conserve · George Washington University · R01 · FY2024 · NR
Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV
$783,330Canhua Xiao · Emory University · R01 · FY2023 · DE
A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial
$783,321Karen Alexander · Friends Research Institute, Inc. · R01 · FY2025 · NR
SHIGA-TOXINS: PRE-CLINICAL ANIMAL MODEL DEVELOPMENT AND THERAPEUTIC TESTING
$783,314Shinichiro Kurosawa · Boston University Medical Campus · U01 · FY2010 · AI
Social-Structural Stressors, Resilience and Sexual Risk Behaviors Among Black Men
$783,310Ingrid Alisa Bowleg · Drexel University · R01 · FY2012 · MH
Informing best practices for Substance-use Treatment with Real-world evidence for people with Opioid Use Disorder and HIV (STRONg)
$783,300Catherine Lesko · Johns Hopkins University · R01 · FY2025 · DA
Adolescent Medicine Trials Network for HIV/AIDS Interve*
$783,300Lawrence D'angelo · Children'S Research Institute · U01 · FY2009 · HD
The HUSH complex in HIV-1 latency
$783,287Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R37 · FY2023 · AI
The HUSH complex in HIV-1 latency
$783,287Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R37 · FY2021 · AI
The HUSH complex in HIV-1 latency
$783,287Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R37 · FY2020 · AI
The HUSH complex in HIV-1 latency
$783,287Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R37 · FY2022 · AI
Impact of HIV/SIV Infection on Paneth and Intestinal Stem Cell Interaction
$783,273Bapi Pahar · Tulane University Of Louisiana · R01 · FY2018 · DK
Advanced Mass Spectrometry Facility
$783,233David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Development of a highly-sensitive urine test for tuberculosis (TB) that detects diverse forms of urinary TB lipoarabinomannan (uLAM)
$783,218Abraham Pinter · Rutgers Biomedical And Health Sciences · R56 · FY2022 · AI
The barcode project: a strategy to track the early naïve reservoir
$783,206Una T O'Doherty · Emory University · R01 · FY2024 · AI
HIV EVALUATION ACTIVITIES WITH HIGH-RISK, UNDERSERVED POPULATIONS IN SOUTH AFRICA
$783,205Tim Lane · University Of California, San Francisco · U2G · FY2013 · GH
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,177Lishan Su · University Of Maryland Baltimore · R01 · FY2021 · AI